Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$67,201,720
+$16,483,922 QoQ
Shares Held
267,055
+14.5% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#325
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2022CallValue
$46,705
CallShares
348
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NATIXIS holds $664,875,786 across 10 Drug Manufacturers - General names. ABBV ranks #4 (10.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
707,790 | $179,757,426 | |
| 2 | LLY |
ELI LILLY & Co
|
133,441 | $160,053,151 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
2,519,137 | $145,152,673 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
267,055 | $67,201,720 | |
| 5 | NVO |
Novo Nordisk A S
|
824,229 | $39,513,538 | |
| 6 | MRK |
Merck & Co., Inc.
|
280,187 | $36,004,029 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
143,928 | $18,183,863 | |
| 8 | PFE |
Pfizer Inc
|
632,317 | $15,226,193 |
All Filings in ABBV
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,201,720 | 267,055 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $50,717,798 | 233,196 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $78,914,962 | 345,376 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $51,665,372 | 223,138 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $43,739,496 | 235,640 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $48,719,895 | 232,531 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $13,436,430 | 75,613 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $76,794,047 | 388,870 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $110,593,865 | 644,787 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $30,575,317 | 167,904 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $58,461,811 | 377,246 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $55,591,181 | 372,945 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $66,982,365 | 497,160 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $63,344,633 | 397,469 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $97,077,672 | 600,691 | Shares | Defined | 2023-02-24 | |
| 2022-09-30 | $0 | 0 | Put | Sole | 2022-11-14 | |
| 2022-09-30 | $47,481,484 | 353,785 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $46,705 | 348 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $0 | 0 | Put | Sole | 2022-08-12 | |
| 2022-06-30 | $51,461 | 336 | Call | Sole | 2022-08-12 | |
| 2022-06-30 | $57,430,711 | 374,972 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $28,396,646 | 175,169 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $17,875,237 | 132,018 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $21,238,740 | 196,892 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $74,363,463 | 660,187 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,295,393 | 11,970 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $134,728,695 | 1,257,384 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $72,434,127 | 826,968 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $134,324,476 | 1,368,145 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $142,683,603 | 1,872,734 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||